NCT06235710Completed
Prevalence of Musculoskeletal Complaints in Nursing Home Residents
Source: ClinicalTrials.gov · Last updated 30 Sept 2025
Brief summary (registry, in English)
The goal of this observational study is to investigate the prevalence of joint complaints in nursing home residents with and without dementia. Primary objective: Number of tender or swollen joints. Secondary objectives: 1. Only when it is possible for the nursing home resident to provide us this information: how nursing home residents themselves assess the severity of their joint complaints that day (at that time). If the nursing home resident cannot answer this question (reliably), the investigators use the Pain Assessment Checklist for Seniors with Severe Dementia (PACSLAC-D). 2. Investigate mobility limitations among nursing home residents. 3. To understand whether an accurate (differential) diagnosis for the joint complaints is reported in the electronic files. During the study, a standard physical examination of the musculoskeletal system will performed. Nursing home residents allocated in group 1 (no dementia) also provide an answer on 3 non-incriminating questions (severity of joint complaints, pain in general and general health). Nursing home residents allocated in group 2 (dementia) answer, if possible, 1 non-incriminating question (pain in joints at that moment). These question(s) and the physical examination are also widely used in daily clinical practice. No further incriminating questions or questionnaires will be administered. If the nursing home resident cannot answer this question (reliably), the investigators use the PACSLAC-D.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 23 Jan 2024
- Start date
- 18 Jan 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- Maastricht University Medical Center
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT06235710
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 18 Jan 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis dementia;
Other
- Life expectancy \< 2 weeks (definition terminal nursing home resident). Exclusion criteria, group 2
- Life expectancy \< 2 weeks (definition terminal nursing home resident).
- If, on the basis of an already known pattern of behaviour, it is expected that the potential participant will resist the proposed research (anticipated behaviour).
Who the study is looking for
- Mentally competent nursing home resident ≥ 65 years;
- No diagnosis of dementia (major neurocognitive disorder according to DSM-5 criteria);
- The nursing home resident provides informed consent to participate in the study.
- Nursing home resident with dementia (major neurocognitive disorder according to DSM-5 criteria) ≥ 65 years;
- The legal representative of the nursing home resident provides informed consent to participate in the study.
Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cicero Zorggroep Coordinator of this site? Confirm its status | Brunssum | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.